Neurocrine Biosciences to Present at the 2003 Credit Suisse First Boston
Health Care Conference
Health Care Conference
SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will be presenting at the 2003 Credit Suisse First Boston Health Care Conference in Phoenix tomorrow, Wednesday, November 12, 2003 at 4:30 PM Eastern Time; 2:30 PM Mountain Time and 1:30 PM Pacific Time. The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com . Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary audio software.
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. The presentation will be available for replay approximately 24 hours after the live presentation and will be archived until Wednesday, November 26, 2003.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.
Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .
SOURCE Neurocrine Biosciences, Inc.